Literature DB >> 1670597

Comparison of vecuronium- and atracurium-induced neuromuscular blockade in postpartum and nonpregnant patients.

K S Khuenl-Brady1, J Koller, P Mair, F Pühringer, G Mitterschiffthaler.   

Abstract

The time-course of action of 0.1 mg/kg vecuronium and 0.5 mg/kg atracurium was investigated in nonpregnant and in postpartum patients within 4 days after delivery. The clinical duration of vecuronium, but not that of atracurium, was significantly prolonged in the latter group (P less than 0.001) and averaged 36 +/- 6 and 37 +/- 4 min for atracurium and 32 +/- 6 and 49 +/- 10 min for vecuronium in nonpregnant and in postpartum patients, respectively (mean +/- SD). In additional in vitro experiments in the rat phrenic nerve-hemidiaphragm preparation no difference could be observed in the neuromuscular blocking effects of vecuronium in postpartum and nonpregnant female rats. It is concluded that pregnancy-induced changes in liver blood flow and/or competition for the liver uptake of sexual hormones might interfere with the hepatic clearance of vecuronium in postpartum patients and thereby cause the observed prolongation of neuromuscular blockade.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1670597     DOI: 10.1213/00000539-199101000-00020

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  4 in total

Review 1.  Clinical pharmacokinetics of neuromuscular relaxants in pregnancy.

Authors:  J Guay; Y Grenier; F Varin
Journal:  Clin Pharmacokinet       Date:  1998-06       Impact factor: 6.447

Review 2.  Pharmacokinetic optimisation of general anaesthesia in pregnancy.

Authors:  T Gin
Journal:  Clin Pharmacokinet       Date:  1993-07       Impact factor: 6.447

3.  Onset of vecuronium neuromuscular block is more rapid in patients undergoing caesarean section.

Authors:  A Baraka; S Jabbour; Z Tabboush; A Sibai; A Bijjani; K Karam
Journal:  Can J Anaesth       Date:  1992-02       Impact factor: 5.063

4.  Neuromuscular effects of vecuronium and neostigmine in Montreal and Paris.

Authors:  Y Salib; J Frossard; B Plaud; B Debaene; C Meistelman; F Donati
Journal:  Can J Anaesth       Date:  1994-10       Impact factor: 5.063

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.